Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials (Q47556374)
Jump to navigation
Jump to search
scientific article published on 19 January 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials |
scientific article published on 19 January 2018 |
Statements
1 reference
Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials (English)
1 reference
Michelle R Mahoney
1 reference
Sandra P D'Angelo
1 reference
Brian A Van Tine
1 reference
James Atkins
1 reference
Balkrishna N Jahagirdar
1 reference
Cristina R Antonescu
1 reference
Elise Horvath
1 reference
William D Tap
1 reference
Gary K Schwartz
1 reference
Howard Streicher
1 reference
19 January 2018
1 reference